TRS 1060 - Annex 2: WHO good practice considerations for the prevention and control of nitrosamines in pharmaceutical products
15 April 2025
| Technical document
Overview
This guideline is applicable to all manufacturers and packers of excipients, active pharmaceutical ingredients, processing aids and finished pharmaceutical products.
WHO Team
Access to Medicines and Health Products (MHP),
Health Product Policy and Standards (HPS),
Norms and Standards for Pharmaceuticals (NSP),
Technical Standards and Specifications (TSS)
Number of pages
23